Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry

Clinical and Experimental Metastasis

Volumn 17, Issue 6, 1999, Pages 537-544

  Schmidt, Christina M ^a   Settle, Steven L ^a   Keene, Jeffery L ^a   Westlin, William F ^a   Nickols, G Allen ^a   Griggs, David W ^a  

^a MONSANTO COMPANY   (United States)

Author keywords

Breast carcinoma; Flow cytometry; Green fluorescent protein; Orthotopic metastasis; Time course; Xenograft model

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CELL CULTURE; CELL MIGRATION; DISEASE ACTIVITY; FLOW CYTOMETRY; METASTASIS; MOUSE; NONHUMAN; TUMOR VOLUME;

BREAST NEOPLASMS; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

EID: 0033510649     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006719800907     Document Type: Article

References (39)

1. 1. Woodhouse EC, Chuaqui RE, Liotta LA. General mechanisms of metastasis, Cancer 1997; 80: 1529-37.
2. 2. Ruoslahti E. How cancer spreads, Sci Am 1996; 275: 72-7.
3. 3. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50: 6130-8.
4. 4. Chishima T, Miyagi Y, Wang X, et al. Visualization of the metastatic process by green fluorescent protein expression, Anticancer Res 1997; 17: 2377-84.
5. 5. Farina KL, Wyckoff JB, Rivera J, et al. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res 1998; 58: 2528-32.
6. 6. Lin WC, Pretlow TP, Pretlow TGd, Culp LA, Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res 1990; 50: 2808-17.
7. 7. Melnyk O, Shuman MA, Kim KJ. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res 1996; 56: 921-4.
8. 8. Yang M, Hasegawa S, Jiang P, et al. Widespread skeletal metastatic potential of human lung cancer revealed hy green fluorescent protein expression. Cancer Res 1998; 58: 4217-21.
9. 9. Zhang L, Hellstrom KE, Chen L. Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis 1994; 12: 87-92.
10. 10. Morin JG, Hastings JW. Energy transfer in a bioluminescent system. J Cell Physiol 1971; 77: 313-8.
11. 11. Heim R, Tsien RY. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 1996; 6: 178-82.
12. 12. Cailleau R, Olive M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 1978; 14: 911-5.
13. 13. Price JE. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 1996; 39: 93-102.
14. 14. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717-21.
15. 15. Clarke R. Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat 1996; 46: 255-78.
16. 16. Zhang JF, Hu C, Geng Y, Selm J, Klein SB, et al. Treatment of a human breast cancer xenograft with an adenovirus vector containing an Interferon gene results in rapid regression due to viral oncolysis and gene therapy. Proc Natl Acad Sci USA 1996; 93: 4513-8.
17. 17. Lesoon-Wood LA, Kim WH, Kleinman HK, et al. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther 1995; 6: 395-405.
18. 18. Wang CY, Chang YW. A model for osseous metastasis of human breast cancer established by intrafemur injection of the MDA-MB-435 cells in nude mice. Anticancer Res 1997; 17: 2471-4.
19. 19. Price JE, Zhang RD. Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev 1990; 8: 285-97.
20. 20. Pang SZ, DeBoer DL, Wan Y, et al. An improved green fluorescent protein gene as a vital marker in plants. Plant Physiol 1996; 112: 893-900.
21. 21. Carron CP, Meyer DM, Pegg JA, et al. A peptidomimetic antagonist of the integrin alpha(v)bela3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. Cancer Res 1998; 58: 1930-5.
22. 22. Chishima T, Miyagi Y, Wang X, et al. Metastatic patterns of lung cancer visualized live and in process by green fluorescence protein expression. Clin Exp Metastasis 1997; 15: 547-52.
23. 23. Chishima T, Miyagi Y, Wang X, et al. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 1997; 57: 2042-7.
24. 24. MacDonald TJ, Tabrizi P, Shimada H, et al. Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein. Neurosurgery 1998; 43: 1437-42.
25. 25. Moore A, Marecos E, Simonova M, et al. Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis. Microvasc Res 1998; 56: 145-53.
26. 26. Luzzi KJ, MacDonald JC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998; 153: 865-73.
27. 27. Meyer JS, Wittliff JL. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy. Int J Cancer 1991; 47: 213-20.
28. 28. Chen Z, Smith CW, Kiel D, Van Wacs C. Metasratic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin Exp Metastasis 1997; 15: 527-37.
29. 29. Price JE, Bell C, Frost P. The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice. Int J Cancer 1990; 45: 968-71.
30. 30. Cornetta K, Moore A, Johannessohn M, Sledge GW. Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice. Clin Exp Metastasis 1994; 12: 3-12.
31. 31. Cornil I, Theodorescu D, Man S, et al. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 1991; 88: 6028-32.
32. 32. Wong NC, Mueller BM, Barbas CF, et al. Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis 1998; 16: 50-61.
33. 33. Sung V, Gilles C. Murray A, et al. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp Cell Res 1998; 241: 273-84.
34. 34. Nip J, Brodt P. The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis. Cancer Metastasis Rev 1995; 14: 241-52.
35. 35. Oales AJ, Barraclough R, Rudland PS. The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis 1997; 17: 1-15.
36. 36. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994; 263: 526-9.
37. 37. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, et al. Transfection of thrombospondin I complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994; 54: 6504-11.
38. 38. Lemicux P, Oesterreich S, Lawrence JA, et al. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 1997; 17: 113-23.
39. 39. Price JE. Analyzing the metastatic phenotype. J Cell Bioehem 1994; 56: 16-22.